The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future scientific research projects in the leukodystrophy field. The MDBP is the world’s largest leukodystrophy biorepository, having enrolled over 1,000 individuals affected by leukodystrophies.
Specifically, MDBP researchers hope to uncover new genetic etiologies for individual leukodystrophies, develop biomarkers for use in future clinical trials, and better understand the natural history of these diseases. The knowledge gained from these efforts may help improve the diagnostic tools and treatment options available to patients in the future.
If you are interested in participating in this study, please submit our Referral Survey. Once your survey has been received, an MDBP study coordinator will contact you with additional information.